Health news round up: long-term conditions, cancer drugs and a medicines pricing stand-off Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
MHRA approves first new UTI antibiotic in 30 years Gepotidacin (Blujepa; GSK) is approved for the treatment of uncomplicated UTIs in patients aged 12 years and over, who weigh at least 40kg.…
Tackling systemic barriers through pharmacy practice research This month’s column from the RPS chief scientist’s office includes reflections of recent pharmacy practice research through the lens of Core20PLUS5.…
The Dash review and its impact on the future of patient advocacy Concerns have been raised that NHS ten-year plan proposals may further complicate the patient safety and advocacy system, which Penny Dash has already dubbed a “cluttered landscape”.…
Almost half of pharmacy owners have used personal savings to subsidise NHS services A poll by Community Pharmacy England following the April 2025 funding settlement showed that around 60% of pharmacy owners also expect to reduce staff headcount in 2025.…
Government and APBI fail to reach agreement on cost of branded medicines The levy paid to the government on the sales of branded medicines to the NHS is higher than the rates paid in other countries, such as Ireland, Belgium, Germany and France.…
Designed by AI: the future of antibody drugs Artificial intelligence is enabling the next generation of antibody drugs — and helping to ‘drug the undruggable’. Meet the start-ups that are designing these treatments from scratch.…
NICE draft guidance ‘biggest shake-up’ to type 2 diabetes treatment in a decade The National Institute for Health and Care Excellence said these changes are aimed to address underprescribing and health inequalities related to treatment for type 2 diabetes mellitus.…
Vaccines often overlooked in antimicrobial stewardship, microbiologists warn Attendees of a roundtable organised by the Microbiology Society concluded that there was an “urgent need to strengthen the evidence base for vaccine impact on AMR”.…
Reviewing our clinical services and implementing job planning to get the best out of our pharmacy team How deputy chief pharmacist Poureya Aghakhani and his team have responded to financial pressures to reaffirm their purpose.…
